Home › NDC Lookup › Ingredients › Salicylic Acid › 62673-0059-10
Denorex Extra Strength Salicylic Acid .03 g/mL Shampoo, 296 mL — NDC 62673-0059-10 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Denorex Extra Strength Salicylic Acid .03 g/mL Shampoo, 296 mL — NDC 62673-059-10 (Billing 62673-0059-10)

by Neoteric Cosmetics, Inc. · 296 mL in 1 BOTTLE

This is a package of 296 mL of Denorex Extra Strength Salicylic Acid .03 g/mL Shampoo from Neoteric Cosmetics, Inc., marketed since Jun 2019 and currently FDA-listed, this package's marketing is listed to end Feb 2029. It is this product's only package size.

NDC 62673-0059-10
🏷️ FDA NDC (as labeled) 62673-059-10 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 62673-059-10 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
62673 labeler · 059 product · 10 package
Package marketed since
Jun 17, 2019
Package marketing ended
Feb 28, 2029
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 6267305910 6
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 62673-059-10
Product NDC 62673-059
11-digit billing NDC 62673005910
RxCUI 205023, 1303358
UNII O414PZ4LPZ
Application # M032
SPL Set ID 21d234ff-f379-4bcd-9ba0-90f27c6d3a69
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-06-17
Marketing end 2029-02-28
Route TOPICAL
Dosage form SHAMPOO
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 205023
Why two NDCs? The FDA registers this code as 62673-059-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 62673-0059-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or b...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
62673-0059-10 You're viewing this Main listing 296 mL in 1 BOTTLE 2019-06-17 Feb 28, 2029 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Leader Therapeutic Dandruff Anti-Dandruff, anti-seborrheic dematitis and anti-psoriasis 30 mg/mL 70000-0550-01 Cardinal 133 ml $0.022 — Availability likely —
DHS SAL 4 oz. .035 g/g 00096-0738-04 Person 123.84 g — — FDA listed —
Dhs Sal 30 mg/mL 00096-0812-04 Person 120 ml — — FDA listed —
Walgreens Tplus Salicylic Acid Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 30 mg/mL 00363-2735-01 Walgreen 133 ml — — FDA listed —
Walgreens Dandruff Itchy Dry Scalp Defense Plus Vitamins and Botanicals Anti-dandruff 30 mg/mL 00363-4137-01 Walgreen 325 ml — — FDA listed —
Walgreens 30 mg/mL 00363-9536-07 Walgreens 207 ml — — FDA listed —
Walgreens 30 mg/mL 00363-9537-11 Walgreens 325 ml — — FDA listed —
TriDerma Itchy Scalp 3 g/100g 10738-0045-23 Genuine 370 g — — FDA listed —
TRIDERMA Psoriasis Control 3 g/100mL 10738-0980-50 Genuine 1 tube — — FDA listed —
Selsun Blue Naturals Itchy, Dry Scalp .03 g/mL 41167-6180-03 Chattem, 325 ml — — FDA listed —
Dr. Groot Anti-dandruff Scalp Care 30 mg/mL 43136-0701-01 TAI 300 ml — — FDA listed —
Dr. Groot Anti-dandruff Scalp Care 2 in 1 30 mg/mL 43136-0702-01 TAI 300 ml — — FDA listed —
CVS Health MAXIMUM STRENGTH Therapeutic Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 30 mg/mL 51316-0443-01 CVS 1 bottle — — FDA listed —
Dr. Groot Anti-dandruff Scalp Care 30 mg/mL 53208-0901-36 LG 300 ml — — FDA listed —
Dr. Groot Anti-dandruff Scalp Care 2 in 1 30 mg/mL 53208-0902-36 LG 300 ml — — FDA listed —
Nizoral Psoriasis 3 g/100mL 55505-0202-64 Kramer 1 bottle — — FDA listed —
XtraCare Dandruff Hair Wash 10 g/325g 57337-0053-01 Rejoice 325 g — — FDA listed —
Cantu Guava Ginger Anti Dandruff .03 g/mL 61012-0740-13 PDC 400 ml — — FDA listed —
Denorex Extra Strength .03 g/mLthis 62673-0059-10 Neoteric 296 ml — — FDA listed —
Denorex Multi-Symptom Anti-Dandruff .03 g/mL 62673-0060-10 Neoteric 296 ml — — FDA listed —
Dermarest Psoriasis Medicated 3 g/100mL 63736-0302-24 Insight 1 bottle — — FDA listed —
bhs beautiful hair and scalp 3 g/100mL 64942-1973-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 3 g/100mL 64942-2063-01 Conopco, 400 ml — — FDA listed —
Therapeutic TPlus Salicylic Acid Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 30 mg/mL 67385-0512-01 Garcoa, 133 ml — — FDA listed —
MG217 Psoriasis Therapeutic Conditioner .03 g/g 68093-7242-01 Wisconsin 1 bottle — — FDA listed —
Neutrogena T/Sal Therapeutic 30 mg/mL 69968-0434-01 Kenvue 12 bottles — — FDA listed —
Neutrogena Scalp Therapy Anti-Dandruff Extra Strength 30 mg/mL 69968-0723-01 Kenvue 354 ml — — FDA listed —
NTG T/Sal 3% Salicylic Acid Anti-Dandruff for Scalp Build Up Control 30 mg/mL 69968-0938-08 Kenvue 1 bottle — — FDA listed —
Neutrogena T/Sal Plus 3% Salicylic Acid Anti-Dandruff for Dry, Itchy Scalp Control 30 mg/mL 69968-0939-08 Kenvue 1 bottle — — FDA listed —
Dermaharmony Unscented Bar 3 g/100g 71819-0020-04 D3 113 g — — FDA listed —
Kenkoderm Psoriasis 3 g/100mL 73632-0003-01 Olympus 118 ml — — FDA listed —
Pert 2 in 1 Extra Strength 3 g/100mL 81277-0803-12 Sodalis 355 ml — — FDA listed —
upandup Anti-dandruff with Salicylic Acid Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 30 mg/mL 82442-0743-01 TARGET 355 ml — — FDA listed —
HAIRCARE Physicians Recommended 30 mg/mL 82499-0267-00 LAWRENCE 237 ml — — FDA listed —
Scalp Revival 3 g/100mL 82594-0001-50 Beccair, 248 ml — — FDA listed —
Neoketramin Antifungal Dandruff Seborrheic Dermatitis Psoriasis Treatment 3 g/100mL 83004-0019-01 Rida 1 tube — — Discontinued —
Quality Choice Therapeutic 3 g/100mL 83324-0295-45 Chain 1 bottle — — FDA listed —
Quality Choice Psoriasis 3 g/100mL 83324-0342-11 Chain 1 bottle — — FDA listed —
Dermoia Psoriasis Treatment Salicylic Acid 30 mg/mL 83524-0945-00 Treasurewise 355 ml — — FDA listed —
DermaSolve Medicated 3 g/100g 84285-0101-08 Fortitude 226 g — — FDA listed —
anti-dandruff 3 g/100mL 84558-0010-01 GUANGZHOU 300 ml — — FDA listed —
VERB PRODUCTS Balance Relief Salicylic Acid Dandruff Clinical Strength 30 mg/mL 84607-0545-00 Verb 235 ml — — FDA listed —
Shailee Psoriasis Treatment 3 g/100mL 84938-0008-01 Foshan 1 bottle — — FDA listed —
Pharmlitalia Psoriasis Treatment 3 g/100mL 84938-0019-01 Foshan 1 bottle — — FDA listed —
Listarfe Anti-Dandruff Shampoo. 3 g/100mL 85150-0005-01 Guangzhou 300 ml — — FDA listed —
Quality Choice Therapeutic 3 g/100mL 85161-0295-45 Longway 1 bottle — — FDA listed —
Quality Choice Psoriasis 3 g/100mL 85161-0342-11 Longway 1 bottle — — FDA listed —
Kenkoderm Psoriasis 3 g/100mL 85286-0003-01 Nexgel,Inc. 118 ml — — FDA listed —
RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. 7.5 g/250g 85424-0015-01 RoyceDerm 250 g — — FDA listed —
RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo. 7.5 g/250g 85424-0020-01 RoyceDerm 250 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Jun 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Salicylic Acid Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII 5OCF3O11KX
    A plant-derived surfactant made from coconut oil. It helps mix oil and water ingredients together in the formulation and can improve how the medicine spreads or feels on the skin.
  • UNII 9DBA0SBB0L
    A synthetic red dye derived from coal tar used as a colorant in medicines and cosmetics. It gives tablets, capsules, and liquids their red or pink appearance for identification and visual appeal.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 53UN5B8F4W
    A silicone polymer mixed with polyethylene glycol and meadowfoam oil. It works as an emulsifier and skin-conditioning agent to help blend oil and water components and improve product texture and feel.
  • UNII H3R47K3TBD
    FD&C Blue No. 1 is a synthetic blue dye approved for use in foods and medicines. It serves as a colorant to give the medication its distinctive appearance and help with product identification.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 13W7MDN21W
    A waxy compound made from glycol and stearic acid. It's used as an emulsifier to help blend oil and water-based ingredients, and as a thickener to give the medicine its desired texture and consistency.
  • UNII L7T10EIP3A
    A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
  • UNII WV9CM0O67Z
    Panthenol is a humectant and skin-conditioning agent derived from pantothenic acid. It's added to medicines to help retain moisture and soothe skin irritation.
  • UNII PI1STR9QYH
    A synthetic polymer used as a thickener and film-former in liquid medications. It increases viscosity to improve texture and helps the product adhere to skin or mucous membranes.
  • UNII 34N07GUJ3X
    A synthetic conditioning agent derived from coconut oil. It functions as an emulsifier and thickener, helping blend water and oil-based ingredients together and improving the texture and feel of the formulation.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII O9W3D3YF5U
    A synthetic surfactant derived from petroleum-based olefins. It helps dissolve or suspend active ingredients and other substances in liquid formulations, improving how the medicine mixes and flows.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

19 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAqua\Water\Eau, Sodium C14-16 olefin sulfonate, PPG-2 Hydroxyethyl Cocamide, Propylene glycol, Glycol distearate, Menthol, Cocamidopropyl betaine, Fragrance\Parfum, Panthenol, Tocopheryl acetate, Glycerin, Dimethicone PEG-8 Meadowfoamate, Polyquaternium-10, Sodium chloride, Sodium citrate, Sodium hydroxide, CI 15985 (Yellow 6), CI 47005 (Yellow 10), CI 17200 (Red 33), CI 42090 (Blue 1)

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNeoteric Cosmetics, Inc.
FDA applicationM032 (OTC MONOGRAPH DRUG)
Labeler code62673
First marketedJun 2019
Product typeHuman Otc Drug
Portfolio6 products on file

More NDCs from Neoteric Cosmetics, Inc. labeler code 62673

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 24 words ▾

Uses Reduces and helps prevent recurrence of these symptoms of dandruff, seborrheic dermatitis and psoriasis. • scalp irritation and itching • flaking • scaling

⏱️ Dosage and Administration 41 words ▾

Directions for best results, use at least twice a week or as directed by a doctor. shake well before use. • apply to wet hair. massage into scalp, leave lather on for several minutes. rinse thoroughly and repeat for maximum relief.

⚠️ Warnings 77 words ▾

Warnings For external use only. Ask a doctor before use if you have a condition that covers a large area of body. When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor If condition worsens or does not improve after regular use of this product as directed. Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Salicylic acid 3%

🧪 Inactive Ingredients 48 words ▾

Inactive ingredients Aqua\Water\Eau, Sodium C14-16 olefin sulfonate, PPG-2 Hydroxyethyl Cocamide, Propylene glycol, Glycol distearate, Menthol, Cocamidopropyl betaine, Fragrance\Parfum, Panthenol, Tocopheryl acetate, Glycerin, Dimethicone PEG-8 Meadowfoamate, Polyquaternium-10, Sodium chloride, Sodium citrate, Sodium hydroxide, CI 15985 (Yellow 6), CI 47005 (Yellow 10), CI 17200 (Red 33), CI 42090 (Blue 1)

🎯 Purpose 5 words ▾

Purpose Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis

📄 Ask a Doctor Before Use If 17 words ▾

Ask a doctor before use if you have a condition that covers a large area of body.

📄 When Using This Product 15 words ▾

When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 8 words ▾

Questions? Call 1-888-398-1382 email [email protected] or visit www.denorex.com

📄 Package Label / Principal Display Panel 52 words ▾

PRINCIPAL DISPLAY PANEL EXTRA STRENGTH Denorex® MULTI-SYMPTOM MEDICATED ANTI-DANDRUFF SHAMPOO + CONDITIONER SALICYLIC ACID 3% / DANDRUFF, SEBORRHEIC DEMATITIS + PSORIASIS EFFECTIVE RELIEF OF 6 DANDRUFF SYMPTOMS FLAKING & SCALING DRYNESS SCALP BUILDUP IRRITATION ITCHING REDNESS associated with dandruff, seborrheic dermatitis + psoriasis 3% SALICYLIC ACID 10 FL OZ. (296 ml) LABEL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Denorex Extra Strength (this brand).

Top reported reactions

Vomiting216
Pruritus205
Weight Decreased188
Condition Aggravated184
Urticaria184
Weight Increased183
Hypertension181

Age at onset

Neonate7
Infant1
Child8
Adolescent5
Adult170
Elderly94

Reporter sex

1,855 reports
Male · 37%
Female · 63%
Unknown · 0%

Serious outcomes

Hospitalization622
Death611
Life-threatening174
Disabling124
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 253 93
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Neoteric Cosmetics, Inc. has reported a marketing end date of 2029-02-28, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Neoteric Cosmetics, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 62673-0017-94 · Neoteric 62673-0060-10 · Neoteric →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.